DYAI
Dyadic International, Inc.
Healthcare · Biotechnology · NCM
$0.73
Close 2026-05-15
✓ ETHICAL PASS
HIGH
Data Confidence: 86%
Full financial profile available
Market Cap
$26.6M
Trailing P/E
Forward P/E
-2.28
Rev Growth
+182.3%
Profit Margin
-191.5%
ROE
-2826.9%
Analyst Target
$7.00
Recommendation
STRONG BUY
About Dyadic International, Inc.

Dyadic International, Inc., together with its subsidiaries, a biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States. The company offers Dapibus Protein Production Platform, a proprietary expression system designed to produce non-animal proteins and enzymes for non-pharmaceutical markets, including life sciences, food and nutrition, and bio-industrial sector; and C1 Protein Production Platform, a thermophilic fungal platform for large-scale production of proteins. It has a research and development agreement with VTT Technical Research Centre of Finland, Ltd; license agreement with Rubic One Health to develop various livestock vaccines; and sub-license agreement with Phibro Animal Health/Abic Biological Laboratories to develop vaccines and treatments for livestock diseases. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.

Opportunity Summary
Passes all ethical screens. Ranks better than 83% of screened stocks.
Ethical Screen
Business ActivityPASS
Debt Ratio (0.20%)PASS
Cash Ratio (0.28%)PASS
Receivables Ratio (0.00%)PASS
Revenue Ratio (0.00%)PASS
OverallPASS
Score Ethical: 81.9
Score Valuation: 33.0
Score Quality: 33.8
Score Combined: 41.1
· Tier: FAIR VALUE

Full Analysis

Opportunity scores, earnings history, insider transactions, institutional holders, analyst consensus, and more.

Unlock with Membership
Opportunity Scores
Valuation50.0
Quality25.0
Cash Flow50.0
Moat50.0
Balance Sheet100.0
Debt Purity40.8
Liquid Purity14.3
Rev Purity100.0
Compliance50.4
Tier: BRONZE · Score: 45.4 · Rank: #3046
Earnings History (Last 8 Quarters)
DateEPS Est.Reported EPSSurprise %
2026-08-12-0.04Pending--
2026-05-13-0.04-0.05-11.1%
2026-03-25-0.04-0.06-33.3%
2025-11-12-0.04-0.06-38.5%
2025-08-13-0.06-0.06--
2025-03-26-0.04-0.05-25.0%
2024-11-12-0.07-0.01+85.7%
2024-08-13-0.06-0.07-7.7%
Quarterly Financials
PeriodRevenueNet IncomeEBITDAGross ProfitOp. IncomeEPS
2026-03-31$623.6K-$2.0M-$1.8M-$168.2K-$1.9M-0.05
2025-12-31$235.7K-$1.6M-$1.5M-$148.9K-$1.5M
2025-09-30$350.0K-$2.0M-$1.9M-$674.0K-$1.9M-0.06
2025-06-30$463.4K-$1.8M-$1.7M-$150.1K-$1.7M-0.06
2025-03-31$183.1K-$2.0M-$1.9M-$114.6K-$2.0M-0.07
2024-12-31
Insider Transactions
DateNameRoleSharesValue
2026-01-02EMALFARB MARK AChief Executive Officer102,609--
2026-01-02RAWSON PING WANGChief Financial Officer29,158--
2026-01-02TCHELET RONENOfficer18,064--
2026-01-02HAZELTON JOSEPH PPresident36,418--
2026-01-02KAYE JACKDirector21,552--
2026-01-02LUCY PATRICK KDirector21,552--
2026-01-02HERBST SETH J. M.D.Director21,552--
2025-08-01HAZELTON JOSEPH PPresident26,000$24.7K
2025-06-20TARNOK MICHAEL PDirector10,776--
2025-06-20BOSE ARINDAMDirector10,776--
Top Institutional Holders
HolderSharesValue% Held
Apis Capital Advisors, LLC1.3M$964.9K0.0%
Vanguard Capital Management LLC928.2K$704.7K0.0%
Chapin Davis, Inc.888.0K$674.2K0.0%
Truist Financial Corp326.2K$247.7K0.0%
Geode Capital Management, LLC313.5K$238.0K0.0%
Blackrock Inc.275.4K$209.1K0.0%
Vanguard Fiduciary Trust Co139.5K$105.9K0.0%
Marathon Capital Management110.0K$83.5K0.0%
Sage Mountain Advisors, LLC106.6K$80.9K0.0%
Landscape Capital Management LLC97.0K$73.7K0.0%
Analyst Recommendations
2 Months Ago
1
1 analysts
Last Month
1
1 analysts
Current
1
1 analysts
Strong Buy Buy Hold Sell Strong Sell
Additional Fundamentals
Enterprise Value
$27.1M
Price/Book
-69.02
Analysts
2
Total Revenue (TTM)
$3.8M
Total Debt
$5.1M
Rec. Mean
1.00
Short Ratio
0.92
Short % Float
0.0%

Elite Intelligence

Trade Consideration with position sizing, convergence signals, and risk analysis. Available to Elite members.

Upgrade to Elite
Trade Consideration
The Opportunity
Score 41.1 (P46 — top 53.8% of scored tickers). Ethical PASS. 2 analysts at Strong Buy.
Price: $0.73 | Target: $6.00 (+722%)
Score
41
Moat
Conviction
Standard
Upside
+722%
The Fundamentals
Revenue Growth+182.3%
Profit Margin-191.5%
ROE-2826.9%
Forward P/E-2.3
Market Cap$26.6M
Earnings Track Record
DateEstimateReportedSurprise
2026-08-12$-0.04Pending
2026-05-13$-0.04$-0.05-11.1%
2026-03-25$-0.04$-0.06-33.3%
2025-11-12$-0.04$-0.06-38.5%
2025-08-13$-0.06$-0.06
2025-03-26$-0.04$-0.05-25.0%
Position Sizing Scenarios
Stop: $0.62 (-15%) | Entry: $0.73
SharesCostProfit to TargetR:R
To Consensus ($6.00, 2 analysts)
10$7.30+$52.70 (722%)47.9R
50$36.50+$263.50 (722%)47.9R
100$73.00+$527.00 (722%)47.9R
Risk Factors
  • No elevated risk flags in current data
The Verdict
Dyadic International, Inc. passes all ethical screens and is growing revenue at +182.3%.
Quantitative Grade

A single score combining all analytical layers below. A is strongest, D is weakest.

D
Quant Score
35.9
Risk Grade
Layers
8
Quality: STRONG_EARNINGS_DRIFT
Risk Profile

How much could this ticker lose on a bad day? These metrics measure worst-case scenarios from historical data.

VaR 95%
-7.4%
worst expected daily loss, 19 in 20 days
CVaR 95%
-9.7%
avg loss on the worst 5% of days
Annual Volatility
Sortino Ratio
-1.07
above 1.0 is good
Max Drawdown
-70.0%
Worst Day
Forward Outlook

Based on 10,000 simulated price paths, here is the probability of where this ticker could be in 30, 60, and 90 days.

30d Prob Up
90d Prob Up
Median Return 30d
Liquidity Score
50
Liquidity Grade
MODERATE
Trend & Momentum

What direction is this ticker actually moving, filtered through noise? Is it speeding up or slowing down?

Kalman Trend
Trend Strength
Momentum Signal
HMM Regime
RSI Signal
Technical Signals

Classic chart signals that institutional traders monitor. Golden Cross is bullish, Death Cross is bearish.

MA Crossover
BELOW_200
Bollinger Position
UPPER_HALF
Beta
Relative Volume
0.7x
Short Interest
Financial Health

Is this company financially sound? The Z-Score measures bankruptcy risk. The F-Score measures fundamental strength.

Altman Z-Score
below 1.81 = distress zone
Piotroski F-Score
Earnings Beat Rate
12.5%
Earnings Consistency
Correlations

These tickers tend to move together (positive) or in opposite directions (negative). Useful for portfolio diversification.

Most Correlated
TickerCorrelation
GGRP0.216
WYFI0.211
MVIS0.198
MBOT0.196
VOYG0.195
Inverse Correlated
TickerCorrelation
NAVN-0.254
AWK-0.164
SUNC-0.163
ATO-0.137
CME-0.132
Seasonality

Does this ticker have consistent patterns on certain days or months? Historical tendencies, not guarantees.

Best Day
Wednesday
Worst Day
Monday
Best Month
Nov
Worst Month
Jun
Fri-Mon Effect
0.7304460979440759
Earnings Drift

After this company beats earnings, does the price keep going up? Drift tracks post-earnings momentum.

Avg Drift After Beat
+44.7%
Beat Drift Positive %
100.0%
Consistency
Momentum Rankings

How does this ticker's recent performance compare to the entire universe? Ranked across 1, 3, 6, and 12-month returns.

1M Return
-11.6%
3M Return
-7.3%
6M Return
-18.3%
12M Return
-27.6%
Momentum Rank
#3937
Momentum Signal
DOWN

Get our daily market read free. Join thousands of traders.

Free Explorer Access